secwatch.observer — SEC 8-K summary
======================================

Issuer:     TG THERAPEUTICS, INC. (TGTX)
CIK:        0001001316
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001558370-23-011140
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TG Therapeutics shareholders reject say-on-pay and share increase at annual meeting
--------------------------------------------------------------------------------

- Advisory say-on-pay failed: 26.0M For (37.4%) vs 43.5M Against (62.6%).
- Proposal to increase authorized shares from 175M to 200M failed; 69.9M For but not majority of outstanding 149.4M shares.
- Only directors Michael Weiss (75.8%) and Laurence Charney (66.1%) received majority for; others <60%.
- Ratification of KPMG as auditor approved with 102.3M For (99.8% of votes cast).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/0001558370-23-011140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/tgtx-20230614x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer